| :: intensive lipid lowering with atorvastatin |
4. Atorvastatin 10mg and 20mg will not be routinely available from pharmacy. Intensive lipid lowering therapy [reserved for patients who fail to reach target,
In the Reversal of Atherosclerosis with Aggressive Lipid Lowering in the moderate regimen or 80 mg of atorvastatin daily in the intensive
CLEVELAND, March 2 /PRNewswire/ -- The first head-to-head comparison of two popular | Article from PR Newswire March 2, 2004.
The Incremental Decrease in End Points Through Aggressive Lipid Lowering ( IDEAL) study compared the effects of intensive (80 mg/d of atorvastatin) vs
The current sub-analysis of the TNT study investigates the effect of intensive lipid lowering with atorvastatin (ATV) 80mg on the incidence of coronary events
[19] J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter and J.C. Fruchart et al., Intensive lipid lowering with atorvastatin in patients with stable coronary
John C. LaRosa, Scott M. Grundy, David D. Waters et al. New England Journal of Medicine, Vol. 352, No. 14. (07 April 2005), pp. 1425-1435.
Intensive Lipid Lowering Treatment with Atorvastatin Reduces Risk of Stroke. Dr. Jaime Fernández de Bobadilla. Pfizer Spain, Madrid, Spain. Intensive lipid
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with All patients were instructed to fast for 8 intensive therapy, and the .
In randomized clinical trials, intensive LLT (lipid-lowering therapy) with atorvastatin had a beneficial effect by slowing the progression of coronary atherosclerosis
For the purpose of this review, an intensive lipid-lowering strategy was defined as either atorvastatin 80 mg/day, rosuvastatin 40 mg/day or
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005; 352(14): 1425-34. Ray KK, Cannon CP,
POST ACUTE CORONARY SYDROME (ACS) INTENSIVE LIPID LOWERING. THERAPY DO NOT BACKTITRATE ATORVASTATIN DOSE. • Triglycerides
The goal of the trial was to evaluate the effect of atorvastatin compared with placebo . Intensive Lipid Lowering and TVR (Clinical Restenosis) and Non-TVR
Intensive versus moderate lipid lowering with statins after acute coronary Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in
Pravastatin or atorvastatin evaluation and infection therapy - thrombolysis in myocardial infarction 22 investigators. intensive versus moderate lipid lowering with
of intensive lipid lowering (4 weeks of 80 mg atorvastatin once daily) on that intensive lipid lowering by atorvastatin has no effect on NO availability in forearm
Maximal doses of rosuvastatin and atorvastatin resulted in significant Patients were excluded if they had received intensive lipid-lowering
New Orleans, LA - Intensive lipid lowering with atorvastatin (Lipitor®, Pfizer) 80 mg daily provided greater protection from death and
This subanalysis of the Treating to New Targets study investigated how intensive lipid lowering with 80 mg of atorvastatin affects renal function
reach cholesterol targets on simvastatin. 40mg daily. Atorvastatin 80 mg daily is no longer recommended for 'intensive' lipid lowering in patients with acute
patients received for 6 months atorvastatin (10mg-80mg) to target LDL<100mg/dl. At the end, we found that intensive lipid-lowering therapy with atorvastatin
atorvastatin causes a significant lipid-lowering and antiinflammatory effects similar to significant clinical benefit by intensive lipid-lowering therapy. The use of
Intensive lipid lowering with 80 mg/d of atorvastatin provided clinically significant added benefit compared with 10 mg/d of atorvastatin in terms of reduced risk for
Objectives: To evaluate the effect of intensive lipid-lowering treatment on coronary Results: 48 patients were randomly assigned to atorvastatin and 54 to
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. New Engl J Med 2005;352:1425-35. CrossRefMedlineOrder article via
intensive lipid-lowering treatment with atorvastatin reduced progression of coronary Intensive lipid-lowering treatment with atorvastatin reduced progression of
atorVastatin Evaluation and Infection Therapy (PROVE-IT)5 studies have shown that lowering LDL-cholesterol more intensively, to a value of at least
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P,
intensive lipid lowering with atorvastatin in patients with stable coronary disease intensive lipid lowering with atorvastatin in patients with stable
James Shepherd, John Kastelein, Vera Bittner et al. Journal of the American College of Cardiology, Vol. 51, No. 15. (2008), 1448. update.
Pitavastatin: efficacy and safety in intensive lipid lowering potent low-density lipoprotein-cholesterol-lowering effects similar to atorvastatin and rosuvastatin.
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35. 9. Ridker PM, Danielson E,
(IDEAL) and Treating to New Targets (TNT) trials compared intensive lipid- lowering therapy with atorvastatin 80 mg/day with moderate-dose statin therapy
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. N Engl J Med 2005; 352:1425-1435. Pedersen TR
-blind therapy and received either 10 mg or 80 mg of atorvastatin mortality. CONCLUSIONS: Intensive lipid-lowering therapy with 80 mg of
2005;352:1425-35. Intensive Lipid Lowering with Atorvastatin. in Patients with Stable Coronary Disease. LaRosa JC et al. N Engl J Med. 2005;352:1425-35.
Two recently published related studies addressed this question by comparing intensive lipid lowering with atorvastatin (Lipitor, Pfizer) 80
ORLANDO, Fla -- March 31, 2009 -- Intensive lipid-lowering therapy significantly depletes to 1 of 3 lipid-lowering regimens: (1) atorvastatin 10 to 80 mg/day;
The Treating to New Targets (TNT) study demonstrated that intensive lipid- lowering therapy with atorvastatin 80 mg/day was associated with a significant
more intensive LDL cholesterol lowering to approx- imately 70 mg per deciliter ( 1.81 mmol per liter) with the use of 80 mg of atorvastatin daily10 as a mean of
The LDL goals established by the National Cholesterol Education Program . Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
LaRosa JC, Grundy SM,Waters DD, et al.,“Intensive lipid lowering with atorvastatin in patients with stable coronary disease”,. N Engl J Med (2005); 352: pp.
Conclusions For patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin reduced progression of coronary
Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery. Sanjiv J. Shah, David D.
A New Study Shows the Maximum-Dose Lipitor Reduces Heart Attacks, but . Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease: The Treating to New Targets (TNT) Study.
This apparently did not concern the authors, who concluded, “Intensive lipid lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD
The International Network of Cholesterol Skeptics on their criteria for determining whether a side effect might have resulted from atorvastatin. Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels
In the Diabetes Atorvastatin Lipid Intervention study, intensive therapy with 80 mg atorvastatin was significantly (P < 0.001) more effective in lowering LDL
DOI:10.1503/cmaj.050418. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with sta
It is uncertain whether intensive lipid-lowering is more effective than standard atorvastatin therapy. Evidence-based Cardiovascular Medicine (June 2006), 10 ( 2)
Atorvastatin: beyond lipid-lowering effects in the diabetic population . support a strategy of intensive lipid lowering with statins in patients with diabetes [21].
To compare the effects of moderate lipid-lowering with pravastatin to that of intensive lipid-lowering with atorvastatin on the progression of coronary artery
Critical appraisal: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. Rev. méd. Chile [online]. 2006, vol.134, n.3, pp. 391-394.
Effect of intensive lipid-lowering therapy on telomere erosion in endothelial to 12 months of intensive LLT with atorvastatin or moderate LLT with pravastatin.
What, if any, is the role for lipid-lowering therapy at this time? No significant differences were found between atorvastatin and placebo in the risk of trial was designed to evaluate the early initiation of intensive lipid lowering following ACS,
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. The treating to new targets (TNT) investigators. Citation: N Engl J Med 2005;
Pfizer's Lipitor, Merck's Zocor and AstraZeneca's Crestor are among the leading Heart patients who received intensive cholesterol-lowering therapy in the four
Conclusions: Intensive lipid-lowering using atorvastatin increased prescription drug costs of treating CV disease patients but reduced CV events. Medical cost
atorvastatin brand atorvastatin ezetimibe combination atorvastatin breast cancer risk method hplc atorvastatin intensive lipid lowering with atorvastatin in
Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease: The TNT (Treating to New Targets) Study
Cholesterol-lowering therapy with 3-hydroxy-3-methylglutaryl coenzyme A The MIRACL study established that intensive statin therapy with atorvastatin (80
Treatment with intensive lipid-lowering therapy with atorvastatin decreased the LDL-C level from a mean baseline value of 150 mg/dL to a
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Eng J Med 2005; 352: 1425-35. Scirica BM, Morrow DA, Cannon CP et al.
OBJECTIVE—The Treating to New Targets study showed that intensive lipid- lowering therapy with atorvastatin 80 mg/day provides significant clinical benefit
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. Posted on May 28, 2011 by microscopy. The Cheapest drugstore to Buy Lipitor
Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the .. assessment of pitavastatin and atorvastatin in acute coro-
The Alzheimer Research Forum, a dynamic online scientific knowledge base, reports on the latest Alzheimer's scientific research and develops databases of
atorvastatin or to usual care over 4 years.8 In the intensive arm. (lowering LDL- cholesterol to. 2.5mmol/l), a 14% relative reduction in the composite end point of
Successful Intensive Lipid-lowering Therapy Using. Atorvastatin Stabilizes Coronary Artery Plaque as. Assessed by Multi-detector Row Computed Tomography
PROVE-IT with atorvastatin, demonstrated that intensive lipid lowering (to median LDL of 62mg/dL) lowers risk more than moderate (to median LDL of 95mg/dL).
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. New England Journal of Medicine. 352:1425-35, 2005. SPORTIF III and V
Intensive lipid lowering with atorvastatin in patients with stable coronary disease ( 2005). Larosa, JC,; Grundy, SM,; Waters, DD,; Shear, C,; Barter, P,; Fruchart, J,
Intensive Lipid-Lowering Therapy Improves Outcomes in Patients with 25-75 years) were randomly assigned to atorvastatin (Lipitor) 10 mg or
Results of the Treating to New Targets (TNT) trial showed that intensive lipid lowering with atorvastatin 80 mg significantly decreased the risk of cardiovascular
LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352: 1425-1435.
NK, TNT (Treating to New Targets). Investigators: Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease.
We evaluated the effect of intensive lipid lowering (4 weeks of 80 mg atorvastatin once daily) on vasoreactivity in 23 patients with type 2
atorvastatin 80mg by the Cardiologists unless there are any contraindications. See intensive lipid lowering guideline. Reason for change. Patients who are post
Intensive Lipid Lowering With Atorvastatin is Associated With Significant Cardiovascular Benefits in Coronary Patients With Type 2 Diabetes and Chronic Kidney
Final results of REVERSAL show that for patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin 80 mg daily
In the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial, the effects of intensive lipid lowering with atorvastatin 80 mg were
The overall results of TNT found that intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provided significant clinical
Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery. Sanjiv J. Shah, MD*, {dagger} , David D.
intensive lipid lowering with atorvastatin. 80 mg daily delivered significant clinical . What does the evidence tell us about treating very-high-risk patients to an LDL
Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months
In this week's NEJM, Intensive lipid lowering with atorvastatin in patients with stable coronary disease makes an argument in favor of reducing
intensive lipid lowering with atorvastatin in patients with. Discuss recent business , economic or political news that is moving the markets.
Intensive Lipid-Lowering Cuts Risk of Repeat Cardiac Events analyses of PROVE IT-TIMI 22 and IDEAL trials favor high-dose atorvastatin
In the TNT study, intensive lipid lowering with atorvastatin (Lipitor®, Pfizer) 80 mg daily provided greater protection from major cardiovascular
We evaluated the effect of intensive lipid lowering (4 weeks of 80 mg atorvastatin once daily) on vasoreactivity in 23 patients with type 2 diabetes by using
'Effect of intensive lipid-lowering therapy on mortality after acute coronary and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in
Lowering Trial, Impact on Regression (SALTIRE) was to establish whether intensive lipid-lowering therapy with 80 mg of atorvastatin daily
"These results show us that intensive lipid lowering therapy with Lipitor and PROVE-IT clinical trials that Lipitor's intensive lipid lowering can
The trial design was the first to compare intensive vs moderate lipid-lowering total cholesterol and triglycerides decreased significantly in the atorvastatin 80
The authors conclude that intensive lipid-lowering therapy with 80 mg of atorvastatin daily in patients with stable CHD is associated with
Intensive Statin Therapy in Acute Coronary Syndrome: This narrative review Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
Randomized Controlled Trial Demonstrates that Aggressive Lipid Lowering 40 mg (moderate lipid lowering therapy) or atorvastatin 80 mg (intensive lipid
This apparently did not concern the authors, who concluded, "Intensive lipid lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD
The authors of the study, which was sponsored by Pfizer, conclude that intensive lipid lowering with 80mg atorvastatin provided additional
24 Nov 2011 ezetimibe and atorvastatin atorvastatin generic canada advantages of rosuvastatin over atorvastatin intensive lipid lowering with atorvastatin
The Treating to New Targets (TNT) study showed that in patients with stable CHD , intensive lipid lowering with atorvastatin 80 mg daily delivered significant
China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome randomly assigned to receive intensive statin therapy (atorvastatin,
OBJECTIVE — The Treating to New Targets study showed that intensive lipid- lowering therapy with atorvastatin 80 mg/day provides significant clinical benefit
At 34 centers in the United States, 654 patients were randomized to moderate lipid lowering using pravastatin 40 mg or intensive treatment with atorvastatin 80
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425. 4. Michos ED, Blumenthal RS. Prevalence of
Rosuvastatin shows no benefit over Atorvastatin in SATURN
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT)
The lipid reductions with either simvastatin or atorvastatin were comparable. .. Intensive lipid lowering with atorvastatin in patients with stable
(2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. New England Journal of Medicine, 352 (14). pp.
More intensive lipid lowering with atorvastatin (79 vs. 110 mg/dL) was associated with attenuation of plaque progression. While an increase in atheroma volume
Order from the British Library: Intensive Lipid Lowering With Atorvastatin is Associated With Significant Cardiovascular Benefits in Coronary Patients With Type 2
e e. EXTRA. ISSUE NO. 17. Intensive lipid lowering with atorvastatin: the TNT study. The Treating to New Targets (TNT) study1 adds to the growing evidence on
The main TNT trial investigated the effects of lowering LDL cholesterol to showed that intensive lipid-lowering therapy with atorvastatin 80
Results Treatment with statin reduced % coronary diameter stenosis (DS) and was associated with a greater .. Intensive lipid lowering with atorvastatin .
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. Shah SJ, Waters DD, Barter
Intensive versus moderate lipid lowering with statins after acute daily (standard therapy) with 80 mg of atorvastatin daily (intensive therapy).
In recent years, the use of "statin" cholesterol-lowering drugs has elicited concerns about the safety of maximum-dose (also called "intensive-dose") Lipitor ®.
patients.9 Although more intensive lipid-lowering regimens have yielded clinical randomized to double-blind therapy with either atorvastatin. 10 mg/day or 80
LaRosa JC, Grundy SM, Waters DD, et al: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005
atorvastatin indian patients india in atorvastatin brands atorvastatin atorvastatin tablets ip 10 mg atorvastatin brand intensive lipid lowering with atorvastatin in
Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients of atorvastatin 80 mg/day (A80) versus atorvastatin 10 mg/day (A10) in
Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over
Publication » Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with
Intensive lipid-lowering with atorvastatin for secondary prevention in patients Intensive LDL-cholesterol lowering to a mean of 79 mg/dl with atorvastatin 80
Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease
In the TNT study, intensive lipid lowering with atorvastatin (Lipitor, Pfizer) 80 mg daily provided greater protection from major cardiovascular
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. New England Journal of Medicine 2005;352:1425-35. 3. Pitt B. Low-density
Intensive lipid lowering with atorvastatin in coronary disease. Auer J, Lamm G, Eber B. Comment on N Engl J Med. 2004 Apr 8;350(15):1495-504. N Engl J Med.
Correspondence from The New England Journal of Medicine — Intensive Lipid Lowering with Atorvastatin in Coronary Disease.
more intensive lipid lowering provides addi- treatment with atorvastatin, rosuvastatin, or simvastatin greater with rosuvastatin versus atorvastatin or simva-
intensive lipid lowering, as recommended by the latest cardiovascular disease ( CVD) guidelines. AFORRD (Atorvastatin in Factorial with
lowering regimen consisting of 40 mg of pravastatin or an intensive lipid-lowering regi- men consisting of 80 mg of atorvastatin. Main Outcome Measures The
Intensive lipid lowering with statins unnecessary with stable CAD (IDEAL) Patients in the atorvastatin group had higher rates of drug
Atorvastatin 80 mg, a more intensive low-density lipoprotein cholesterol lowering agent, reduced both first and subsequent primary end point
Atorvastatin versus pravastatin: intensive versus moderate lipid lowering. Doggrell SA. The University of Queensland, School of Biomedical Sciences, QLD 4072
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease Atorvastatin definition - Cholesterol Information Produced by Doctors For
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005:352:1425-1435. (6.) Cannon CP, Braunwald E, McCabe
A total of 253 patients were randomized to atorvastatin 80 mg/day (intensive lipid lowering) and 249 patients were randomized to pravastatin 40 mg/day
Title, Intensive lipid lowering with atorvastatin in patients with stable coronary disease. Published in, The New England journal of medicine, Vol. 352, No.
In the Reversing Atherosclerosis with Aggressive Lipid- Lowering Study ( REVERSAL), the effect of intensive lipid lowering with atorvastatin 80 mg and standard
Conclusion We conclude that in elderly AF patients treated with OAC, intensive cholesterol-lowering therapy (atorvastatin 40 mg/day and
The change in the primary end point was made to clarify this role. This modification led to an ,seo money,seo tools.
Clinical Trial: Intensive Lipid Lowering Treatment in Patients With patient will be loaded with 80mg atorvastatin, continued by atorvastatin
In the REVERSAL trial, funded by the manufacturer of atorvastatin, CAD or intensive lipid lowering (80 mg/day of atorvastatin) for 18 months.
OBJECTIVE: To investigate the effect of intensive lipid lowering with high-dose atorvastatin on the incidence of major cardiovascular events compared with
The aggressive lipid-lowering strategy was further in the intensive lipid- lowering arm, where atorvastatin (80
Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with sta- ble CHD provides significant clinical benefit beyond that
(2007) Shepherd et al. Clinical journal of the American Society of Nephrology CJASN. Read by researchers in: 100% Medicine. BACKGROUND AND
were due to a lower statin dosage (atorvastatin 10 mg/day). However, relatively little information is available about the effect of intensive cholesterol-lowering
Intensive lipid lowering in patients with rheumatoid arthritis and were randomly assigned to atorvastatin 80 mg daily or simvastatin 20-40 mg
The Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) study, which evaluated intensive therapy with atorvastatin 80 mg compared with
Intensive LDL-cholesterol lowering to a mean of 79 mg/dl with atorvastatin 80 mg/ day in patients with previous CABG reduces major cardiovascular events by
with a history of CHD, by diagnosis with intravascular ultrasound, suggested that intensive lipid lowering therapy with atorvastatin (80 mg/day)
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with .. the positive effects of intensive lipid lowering among patients with diabetes, it is
Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Atorvastatin 40mg qd plus Omega3-fatty acid 2.0mg qd
Intensive lipid lowering with atorvastatin 80 mg achieved a mean LDL reduction of 46.3% compared with moderate lipid lowering with pravastatin 40 mg which
Atorvastatin 10mg and 20mg will not be available from pharmacy. Intensive lipid lowering therapy: 1. Caution is required to avoid drug interactions and
atorvastatin vs low-moderate dose simvastatin on major coronary events . Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352(14):1425-1435. 4. Shepherd J, Barter P, Carmena R,
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing Intensive lipid-lowering with atorvastatin for secondary prevention in patients after
We now know that maximally intensive lipid-lowering therapy can 80-mg atorvastatin (Lipitor) dosage, a regimen designed to be intensive,
Atorvastatin on sale cheap online using recreationally intensive lipid lowering with atorvastatin how to order online without a prescription. Atorvastatin online no
(2010) Larosa et al. The New England Journal of Medicine. Read by researchers in: 88% Medicine, 7% Biological Sciences. Previous trials have demonstrated
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc 2008; 83: 870-9. [23]
LaRosa J C, Grundy S M, Waters D D et al., the Treating to New Targets (TNT) Investigators, “Intensive Lipid Lowering with Atorvastatin in Patients with Stable
31 May 2001 Reduction with Acute Cholesterol Lowering (MIRACL) Trial tested the hypothesis that intensive lowering of cholesterol with atorvastatin (80
We hypothesized that intensive lipid-lowering therapy would halt the to receive either 80 mg of atorvastatin daily or a matched placebo.
It is still uncertain whether or not statins offer cardiovascular protection in patients with chronic kidney disease (CKD). This study shows that the
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. . Mayo Clin Proc 83(8):870-9 (2008)
For secondary prevention, intensive lipid lowering therapy with atorvastatin 80 mg/day was associated with significant incremental clinical benefit beyond
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352(14):1425-35. Background: It is
pharmacokinetics atorvastatin atorvastatin online pharmacy atorvastatin osteoporosis intensive lipid lowering with atorvastatin in patients with
Intensive lipid-lowering therapy alters atherosclerotic plaque progression, 80 mg atorvastatin daily—which achieves comparable LDL cholesterol reduction to
Dallas, TX - Intensive lipid lowering with atorvastatin (Lipitor, Pfizer) 80 mg did not result in a significant reduction in the primary end point of
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
According to a report published early online in Circulation, intensive lipid lowering with atorvastatin to an LDL level of 2.1 mmol/l, with or without
Lipid modification - CVD prevention Lipid lowering effects
Previous mega trials have demonstrated that lipid lowering therapy with suggested that intensive lipid lowering therapy with atorvastatin (80
“Fetal Deaths And Proximity To Hazardous Waste Sites In Washington State” & “ Intensive Lipid Lowering With Atorvastatin In Patients With
IDEAL trial: simvastatin (20 mg titrated to 40 mg) vs atorvastatin (80 mg) Data from the TNT trial also support intensive lipid-lowering
4. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352: 1425-35.
ORIGINAL ARTICLE. OBJECTIVE: To investigate the effect of intensive lipid lowering with high-dose atorvastatin on the incidence of major cardiovascu-
intensive lipid lowering with atorvastatin in patients with. Post by Bileinselry » Sun May 22, 2011 1:42 am. lovastatin erythropoietin zyprexa class action canada
Pravastatin and Lipitor are both medications that are often prescribed to outcomes of intensive lipid lowering with atorvastatin 80 mg/day and
Targets study investigated how intensive lipid lowering with 80 mg of atorvastatin affects renal function when compared with. 10 mg in patients with coronary
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. N Engl J Med. April 7, 2005 2005;352(14):1425-1435. 31. Jones P, Kafonek
Intensive lipid-lowering treatment with atorvastatin completely halted the progression of atherosclerosis, whereas a moderate lipid-lowering regimen of
This study sought to determine whether the benefit of intensive lipid-lowering A progressive reduction in the benefit of intensive LLT with atorvastatin 80 mg
Some were also potentially affected by the inclusion of other lipid lowering .. Zuckerman A, Wenger NK: Effect of intensive lipid lowering with atorvastatin on
Conclusions-Intensive lipid lowering with atorvastatin to an LDL level of 80 mg/dL , with or without antioxidant vitamins, does not provide any further benefits in
By Chris Berrie VIENNA, AUSTRIA -- September 7, 2007 -- Intensive cholesterol reduction with the statin atorvastatin significantly reduces
Original Article from The New England Journal of Medicine — Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary
Intensive lipid-lowering more protective than standard therapy in ACS The results, from the Pravastatin or Atorvastatin Evaluation and
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352(14):1425-1435. 2. Data on file. Pfizer Inc, New York,
Conclusions: Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provides significant clinical benefit beyond that
The case for intensive lipid management Intensive Lipid Lowering with Atorvastatin High-Dose Atorvastatin after Stroke or Transient Ischaemic Attack
Atorvastatin tablet composition Lipitor benefits atorvastatin calcium? The Million Women Study recruited 1. Intensive lipid lowering with atorvastatin! An emerging
Intervention: Drug: Intensive lipid lowering plus Omega3-fatty acid. Drug: Intensive lipid lowering plus Omega3-fatty acid. Atorvastatin 40mg qd
Intensive lowering of LDL cholesterol with atorvastatin at the highest recommended dose would yield incremental benefit compared with the moderate , most
The aim of this study by researchers from the UK was to investigate the effect of intensive lipid lowering with high-dose atorvastatin on the
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35 (RCT). 10. British National Formulary No 50.
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435. (27.) Kostis JB, Breazno A, LaRosa JC,
2 LaRosa JC, Grundy SM, Waters DD, et alfor the Treating to New Targets Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary
ATLANTA -- March 15, 2010 -- Intensive lipid lowering with atorvastatin significantly reduces the risk of peripheral artery disease (PAD) compared with standard
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Eng J Med 2005;352 (online version). 2 Heart Protection
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12
atorvastatin interactions what is atorvastatin used for atorvastatin molecular weight generic atorvastatin calcium intensive lipid lowering with atorvastatin in
Official Title: Intensive Lipid Lowering Treatment in Patients With by atorvastatin 40mg/d for 30d, then receive atorvastatin 20mg/d for the
Accordingly, the Pravastatin or Atorvastatin Evaluation and Infection .. Our finding of a continued benefit of intensive lipid-lowering therapy
CONCLUSIONS: For patients with coronary heart disease, intensive lipid- lowering treatment with atorvastatin reduced progression of coronary
After 16 weeks of atorvastatin, plasma CoQ10 decreased 45% from 762±301 ng/ ml .. Intensive lipid lowering with atorvastatin in patients with stable coronary
We affirm our conclusion that intensive lipid-lowering therapy in patients with established CHD 65 years of age or older (atorvastatin 80 mg vs. atorvastatin 10
The Benefits of Intensive Lipid Lowering Patients with diabetes and CKD who took 80 mg of atorvastatin had a 35% reduction in relative risk
Intensive lipid-lowering with atorvastatin (80 mg) reduced major cardiovascular events by 22%. Objectives. To assess the cost-effectiveness of
Cleveland, OH - Final results of a comparative study involving two statin drugs showed that intensive lipid-lowering treatment with atorvastatin
the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial, the effects of intensive lipid lowering with atorvastatin 80 mg were compared
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll
Effect of Intensive Lipid Lowering on Progression of Coronary using pravastatin 40 mg or intensive treatment with atorvastatin 80 mg.
In clinical trials, adding ezetimibe (Zetia) to Lipitor lowered cholesterol more at 30 days compared with a 51% reduction with intensive therapy (atorvastatin 80
Objective To determine efficacy and safety of intensive lipid lowering with atorvastatin made in China in coronary artery disease(CAD)patients with high risk
cent change in total atheroma volume. Treatment with intensive lipid-lowering therapy with atorvastatin decreased the LDL-C level from a mean base- line value
pretreatment with intensive lipid-lowering doses of atorvastatin (80 mg/day) also may improve outcomes in patients with ACS undergoing early
acute coronary syndrome (4); angina unstable (1); atorvastatin (10)
Previous trials have demonstrated that lowering low-density lipoprotein (LDL) cholesterol levels bel
4. Expert opinion. Atorvastatin versus pravastatin: intensive versus moderate lipid lowering. Evaluation of: [1] CANNON CP, BRAUNWALD E, MCCABE CH et al.
"Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provides significant clinical benefit beyond
Intensive lipid lowering with statins unnecessary with stable CAD (IDEAL) High -dose atorvastatin vs usual-dose simvastatin for secondary prevention after
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352:1425-35. 2. Committee of Principal Investigators.
Intensive lipid-lowering therapy with high-dose atorvastatin therapy relative to moderate lipid-lowering therapy with low-dose atorvastatin reduces hsCRP better .
Atorvastatin 80 mg, a more intensive low-density lipoprotein cholesterol lowering agent, reduced both first and subsequent primary end point events compared
Impact of the PROVE IT-TIMI 22/REVERSAL trials on trends in intensive vs. that intensive lipid-lowering therapy (atorvastatin 80 milligrams daily) reduced
Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart The authors concluded that intensive high-dose atorvastatin might be
The topic Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New
The study, a meta-analysis titled "Effect of the Magnitude of Lipid Lowering . Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
Comparison of Intensive and Moderate Lipid Lowering with Statins after Acute Coronary Syndromes The Pravastatin or Atorvastatin Evaluation
Click to add/remove this article to your list of 'My Favorites' Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Artery Disease,
'Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina
atorvastatin after stroke or transient ischemic attack. intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on
"These results clearly show the important cardiovascular benefits of intensively lowering cholesterol with Lipitor and the additional benefits that it provides for
TNT sub-study: effects of intensive lipid lowering with atorvastatin on congestive heart failure: subgroup analysis of the treating to new targets (TNT) study
Recently, intensive low density lipoprotein (LDL)-cholesterol lowering with atorvastatin 80 mg/day has been shown to have a greater clinical
To examine effects of intensive lipid lowering therapy with atorvastatin on stabilization of coronary plaque by using optical coherence tomography (OCT) in
Conclusions: Intensive LDL-cholesterol lowering to a mean of 79 mg/dl with atorvastatin 80 mg/day in patients with previous CABG reduces major
NEJM early publication: Intensive lipid lowering with atorvastatin in stable coronary disease. Source: N Engl J Med 2005;352. Published early
▪From the perspective of the Canadian Ministries of Health, intensive lipid- lowering therapy with atorvastatin 80 mg is cost-effective versus atorvastatin 10 mg in
Our objective was to study the effect of the chronic use of atorvastatin .. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
atorvastatin tablets 10mg atorvastatin ezetimibe tablets cost generic atorvastatin intensive lipid lowering with atorvastatin in patients with stable coronary disease
intensive lipid lowering with atorvastatin in patients with Post subject: intensive lipid lowering with atorvastatin in patients with. Post Posted:
Atorvastatin should be used as an adjunct to other lipid-lowering treatments .. of intensive lipid lowering with atorvastatin 80 mg and standard degree of lipid
Intensive Lipid Lowering in Stable Coronary Disease Patients treated with 80 mg of atorvastatin experienced a statistically significant
Intensive lipid-lowering with atorvastatin in patients with stable coronary artery disease. New Engl J Med 2005;352(14):1425-1435. 13. Shek A
intensive cholesterol-lowering therapy and, separately, of folate-based homocysteine-lowering therapy achieved with the atorvastatin regimen was associated
Several large-scale clinical trials have assessed the efficacy of atorvastatin in the Intensive Lipid-Lowering Therapy With Statins for Primary Prevention
Cost-effectiveness of Intensive Lipid Lowering Therapy with 80mg of Atorvastatin, Versus 10mg of Atorvastatin, for Secondary Prevention of
Cost Effectiveness of Intensive Lipid-Lowering Treatment for atorvastatin 80 mg /day (A80) versus atorvastatin 10 mg/day (A10) in patients
Result Search Web for 'intensive lipid lowering with atorvastatin in patients with stable, web search, search engine, metasearch, video search, MetaCrawler.
Objectives: This subanalysis of the TNT (Treating to New Targets) study investigates the effects of intensive lipid lowering with atorvastatin in patients with
Name: